anyaivanova/iStock via Getty Images
Great Growth, Bound To Slow
Thermo Fisher Scientific (TMO) recently released 2Q 2021 results showing 34% revenue growth and 44% non-GAAP EPS growth over 2Q 2020. This strong growth was largely due to non-COVID revenue…
Thermo Fisher – Time To Look Past Covid
Share this article
More News

(JEPI) Market Performance Analysis
November 20, 2026


(SPXI) Long Term Investment Analysis
November 20, 2026


(XUU.U) Long Term Investment Analysis
November 20, 2026


Why (AVLV) Price Action Is Critical for Tactical Trading
November 20, 2026